Skip to main content
Top

Cancer and Metastasis Reviews

Issue 4/2015

Content (18 Articles)

Non-Thematic Review

Retinoblastoma: might photodynamic therapy be an option?

Ricardo Teixo, Mafalda Laranjo, Ana Margarida Abrantes, Gonçalo Brites, Arménio Serra, Rui Proença, Maria Filomena Botelho

Non-Thematic Review

Genetically engineered mucin mouse models for inflammation and cancer

Suhasini Joshi, Sushil Kumar, Sangeeta Bafna, Satyanarayana Rachagani, Kay-Uwe Wagner, Maneesh Jain, Surinder K. Batra

NON-THEMATIC REVIEW

Tetraspanin CD82: a suppressor of solid tumors and a modulator of membrane heterogeneity

Jin Feng, Chao Huang, Jonathan D. Wren, Dao-Wen Wang, Jizhou Yan, Jiexin Zhang, Yujie Sun, Xiao Han, Xin A. Zhang

Open Access NON-THEMATIC REVIEW

The challenge of targeting metastasis

Isaiah J. Fidler, Margaret L. Kripke

Open Access NON-THEMATIC REVIEW

Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies

Mans Broekgaarden, Ruud Weijer, Thomas M. van Gulik, Michael R. Hamblin, Michal Heger

NON-THEMATIC REVIEW

How to be good at being bad: centrosome amplification and mitotic propensity drive intratumoral heterogeneity

Padmashree C. G. Rida, Guilherme Cantuaria, Michelle D. Reid, Omer Kucuk, Ritu Aneja

NON-THEMATIC REVIEW

Integrin αvβ6 sets the stage for colorectal cancer metastasis

D. I. Cantor, H. R. Cheruku, E. C. Nice, M. S. Baker

NON-THEMATIC REVIEW

Neutrophils: important contributors to tumor progression and metastasis

Agnieszka Swierczak, Kellie A. Mouchemore, John A. Hamilton, Robin L. Anderson

Open Access NON-THEMATIC REVIEW

EPLIN: a fundamental actin regulator in cancer metastasis?

Ross J. Collins, Wen G. Jiang, Rachel Hargest, Malcolm D. Mason, Andrew J. Sanders

NON-THEMATIC REVIEW

The origin of prostate metastases: emerging insights

Matteo Santoni, Francesco Piva, Marina Scarpelli, Liang Cheng, Antonio Lopez-Beltran, Francesco Massari, Roberto Iacovelli, Rossana Berardi, Daniele Santini, Rodolfo Montironi

Open Access NON-THEMATIC REVIEW

Protease-activated receptors (PARs)—biology and role in cancer invasion and metastasis

Marek Z. Wojtukiewicz, Dominika Hempel, Ewa Sierko, Stephanie C. Tucker, Kenneth V. Honn

Open Access CLINICAL

Insights into brain metastasis in patients with ALK+ lung cancer: is the brain truly a sanctuary?

Gouji Toyokawa, Takashi Seto, Mitsuhiro Takenoyama, Yukito Ichinose

Open Access CLINICAL

Imaging approaches to assess the therapeutic response of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): current perspectives and future trends of an exciting field in development

Rocio Garcia-Carbonero, Roberto Garcia-Figueiras, Alberto Carmona-Bayonas, Isabel Sevilla, Alex Teule, Maria Quindos, Enrique Grande, Jaume Capdevila, Javier Aller, Javier Arbizu, Paula Jimenez-Fonseca

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine